Biopsy Devices Industry The global biopsy devices market size was valued at USD 2.25 billion in 2023 and is expected to expand at a CAGR of 7.2% from 2024 to 2030. The rising prevalence of cancer, increasing emphasis on minimally invasive surgeries, the presence of untapped opportunities in emerging economies, especially in the Asia Pacific, and improving healthcare infrastructure are among the...

The global biopsy devices market size is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of technologically advanced products, leading to increasing adoption of minimally invasive surgical procedures, is the key factor driving the market. In addition, growing...

The Breast Biopsy Devices Market accounted for USD 1.8 billion in 2023-e and is projected to grow at a CAGR of 9.7% over the forecast period from 2024 to 2030. The market is thriving due to factors such as the increasing number of breast cancer screening programs. Among these, breast biopsy devices hold a critical position, especially in the early detection and management of breast cancer. This...

The Breast Biopsy Devices Market is expected to grow from USD 1.8 billion in 2023-e to USD 3.4 billion by 2030, at a CAGR of 9.7% during the forecast period. Breast cancer is one of the most prevalent forms of cancer among women globally, making early detection and accurate diagnosis critical for effective treatment. A breast biopsy is a key procedure that allows healthcare...

The Breast Biopsy Devices Market accounted for USD 1.8 billion in 2023-e and is projected to grow at a CAGR of 9.7% over the forecast period from 2024 to 2030. The market is thriving due to factors such as the increasing number of breast cancer screening programs. Among these, breast biopsy devices hold a critical position, especially in the early detection and management of breast cancer. This...

The breast biopsy devices market is gaining momentum as awareness of breast cancer screening and diagnostic technologies continues to grow worldwide. In 2023, the market was valued at USD 1.8 billion, and it is projected to nearly double to USD 3.4 billion by 2030, representing a CAGR of 9.7% during the forecast period (2024–2030). This growth reflects...

The global biopsy devices market, which was valued at USD 2.25 billion in 2023, is projected to expand significantly, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2030. Several key factors are contributing to the market's growth, including the rising global prevalence of cancer, an increasing emphasis on minimally invasive surgeries, the presence of untapped...

The global biopsy devices market was valued at USD 2.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2030. This growth is being driven by several key factors, including the rising prevalence of cancer, an increasing emphasis on minimally invasive surgical techniques, the existence of untapped opportunities in emerging...

The global biopsy devices market was valued at USD 2.25 billion in 2023 and is expected to grow at a CAGR of 7.2% from 2024 to 2030. This growth is primarily driven by several factors, including the rising prevalence of cancer worldwide. As cancer rates increase, the demand for early detection and diagnostic tools, including biopsy devices, is expected to rise significantly....